Furthermore, the prognostic significance of SCD1 expression was also revealed in many cancers, such as breast cancer, lung adenocarcinoma, colon cancer and soft tissue sarcomas, which showed that high expression of SCD1 was related to a poor outcome for patients with cancers[14–17]. The gene discussed is SCD; the disease is breast carcinoma.